Increased NO production in lysinuric protein intolerance

Journal of Inherited Metabolic Disease

Volumn 28, Issue 2, 2005, Pages 123-129

  Mannucci, L ^a   Emma, F ^a   Markert, M ^b   Bachmann, C ^b   Boulat, O ^b   Carrozzo, R ^a   Rizzoni, G ^a   Dionisi Vici, C ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CITRULLINE; IMMUNOGLOBULIN; NITRATE; NITRIC OXIDE; NITRITE;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CASE REPORT; CULTURE MEDIUM; DRUG MEGADOSE; FIBROBLAST CULTURE; HUMAN; HYPOTHESIS; IN VITRO STUDY; PATHOGENESIS; PROTEIN INTOLERANCE; SCHOOL CHILD; URINE LEVEL;

ADOLESCENT; AMINO ACID METABOLISM, INBORN ERRORS; ANTIGENS, CD98 LIGHT CHAINS; CELLS, CULTURED; CHILD; CITRULLINE; FIBROBLASTS; HUMANS; LYSINE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES;

EID: 19444377182     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10545-005-5954-x     Document Type: Article

References (12)

1. Borsani G, Bassi MT, Sperandeo MP, et al (1999) SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nature Genetics 21: 297-301.
2. Dall'Asta V, Bussolati O, Sala R, et al (2000) Arginine transport through system y(+)L in cultured human fibroblasts: Normal phenotype of cells from LPI subjects. Am J Physiol Cell Physiol 279: C1829-1837.
3. Dionisi-Vici C, De Felice L, Hachem M, et al (1998) Intravenous immune globulin in lysinuric protein intolerance. J Inherit Metab Dis 21: 95-102.
4. Kamada Y, Nagaretani H, Tamura S, et al (2001) Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance. J Clin Invest 108: 717-724.
5. Mills CD (2001) Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: A life or death issue. Crit Rev Immunol 21: 399-425
6. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012.
7. Pahan K, Sheikh FG, Namboodiri AM, Singh I (1997) Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 100: 2671-2679.
8. Palacin M, Bertran J, Chillaron J, Estevez R, Zorzano A (2004) Lysinuric protein intolerance: Mechanisms of pathophysiology. Mol Genet Metab 81: S27-S37.
9. Simell O, Parto K, Nanto-Salonen K (2000) Transport defects of aminoacids at the cell membrane: Cystinuria, Hartnup disease, and lysinuric protein intolerance. In: Fernandes J, Saudubray JM, Van den Berghe G, eds. Inborn Metabolic Diseases, Diagnosis and Treatment. Berlin: Springer, 265-276.
10. Smith DW, Scriver CR, Tenenhouse HS, Simell O (1987) Lysinuric protein intolerance mutation is expressed in the plasma membrane of cultured skin fibroblasts. Proc Natl Acad Sci USA 84: 7711-7715.
11. Tagan D, Eckert P, Marker M, Feihl F, Schaller MD (1998) Blood nitrate levels in septic and cardiogenic shock. Clin Intensive Care 9: 71-76.
12. Torrents D, Mykkanen J, Pineda M, et al (1999) Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene. Nature Genetics 21: 293-296.